This cohort study analyzed data from a large cohort of women with a diagnosis of breast cancer regardless of age, and we identified pathogenic or likely pathogenic variants in BRCA1 and BRCA2 in 4.4% of Asian patients, 8.1% of African American or Black patients, and 4.8% of White patients. This evidence concerns the gene BRCA2 and breast carcinoma.